دورية أكاديمية

Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression.

التفاصيل البيبلوغرافية
العنوان: Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression.
المؤلفون: Messaris E; First Department of Propaedeutic Surgery, Hippocrateion Hospital, Athens Medical School, University of Athens, Vas Sofias 114, Ano Patisia, Athens 11141, Greece. messaris@compulink.gr, Antonakis PT, Memos N, Chatzigianni E, Leandros E, Konstadoulakis MM
المصدر: International immunopharmacology [Int Immunopharmacol] 2004 Mar; Vol. 4 (3), pp. 455-9.
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print Cited Medium: Print ISSN: 1567-5769 (Print) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam ; New York : Elsevier Science, c2001-
مواضيع طبية MeSH: Apoptosis/*drug effects , Deferoxamine/*pharmacology , Free Radical Scavengers/*pharmacology , Gene Expression/*drug effects , Iron Chelating Agents/*pharmacology , Sepsis/*drug therapy, Animals ; Apoptosis/genetics ; Caspase 8 ; Caspases/biosynthesis ; Cytochromes c/biosynthesis ; Genes, bcl-2 ; Kidney/metabolism ; Liver/metabolism ; Male ; Myocardium/metabolism ; Proto-Oncogene Proteins c-bcl-2/biosynthesis ; Proto-Oncogene Proteins c-bcl-2/genetics ; Rats ; Rats, Wistar ; Sepsis/enzymology ; Sepsis/mortality ; Survival Analysis ; bcl-2-Associated X Protein
مستخلص: Background: Oxidative damage is one of the major factors that lead to cell damage, organ dysfunction and death in sepsis. Thus, an attractive candidate for the pharmacologic treatment of the septic syndrome is desferoxamine (DFX), an antioxidant iron chelator used for the removal of iron and a potential free radical scavenger.
Objective: The impact of DFX administration on the survival of septic animals. The effect on cell integrity and cycle of vital organs.
Methods: Sepsis was induced in 40 rats using the cecal ligation and puncture method (CLP) and 20 rats randomly received twice subcutaneously DFX (total dose: 40 mg/kg). Rats were monitored for 36 h and all vital organs were harvested for pathology examination and immunohistochemical detection of Bax, Bcl-2, cytochrome c and caspase-8 apoptosis regulating proteins.
Results: Mean survival in the DFX group was 34.2 h (median 36.0, S.D. 4.4) and 30.2 h (median 36.0, S.D. 9.1) in the control group (p=0.04), while 36 h after follow up 85% of the DFX-treated rats and 55% of placebo rats were alive (p=0.04). Expression of pro-apoptotic bax protein was significantly increased in the heart, liver and kidney of animals in the DFX group compared to the control group.
Conclusions: Treatment with the polymeric iron chelator DFX significantly increases survival of septic subjects and alters the expression of bax, an apoptosis regulating protein in certain organs (heart, liver and kidney).
المشرفين على المادة: 0 (Bax protein, rat)
0 (Free Radical Scavengers)
0 (Iron Chelating Agents)
0 (Proto-Oncogene Proteins c-bcl-2)
0 (bcl-2-Associated X Protein)
9007-43-6 (Cytochromes c)
EC 3.4.22.- (Casp8 protein, rat)
EC 3.4.22.- (Caspase 8)
EC 3.4.22.- (Caspases)
J06Y7MXW4D (Deferoxamine)
تواريخ الأحداث: Date Created: 20040324 Date Completed: 20050126 Latest Revision: 20131121
رمز التحديث: 20240513
DOI: 10.1016/j.intimp.2004.01.012
PMID: 15037222
قاعدة البيانات: MEDLINE
الوصف
تدمد:1567-5769
DOI:10.1016/j.intimp.2004.01.012